Blood clues could reveal who survives cardiac arrest
NCT ID NCT07113769
Summary
This study aims to find specific markers in the blood that can help doctors predict which patients with sudden cardiac arrest will benefit from a powerful, advanced life support treatment called ECPR. Researchers will analyze blood samples from about 130 patients before and after receiving ECPR, looking at proteins, chemicals, and tiny blood cell changes. The goal is to develop better tools to guide treatment decisions and improve survival chances for these critically ill patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ARREST are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fuwai Central China Cardiovascular Hospital
RECRUITINGZhengzhou, Henan, China
Conditions
Explore the condition pages connected to this study.